TILs Taking on Solid Tumors
Credit: Author supplied In February 2024, the FDA approved the first T-cell therapy for a solid tumor: Amtagvi (lifileucel), developed by Iovance Biotherapeutics. The therapy is indicated for adults with advanced melanoma – after patients have tried other …